Cramer Rosenthal Mcglynn LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Cramer Rosenthal Mcglynn LLC

  • $1.63 Billion
  • Q2 2024

A detailed history of Cramer Rosenthal Mcglynn LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Cramer Rosenthal Mcglynn LLC holds 56,624 shares of XBI stock, worth $5.52 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
56,624
Previous 49,918 13.43%
Holding current value
$5.52 Million
Previous $4.74 Million 10.83%
% of portfolio
0.32%
Previous 0.27%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$82.22 - $94.12 $551,367 - $631,168
6,706 Added 13.43%
56,624 $5.25 Million
Q1 2024

May 14, 2024
BUY
$87.05 - $102.89 $1.54 Million - $1.82 Million
17,675 Added 54.82%
49,918 $4.74 Million
Q4 2023

Feb 13, 2024
BUY
$64.12 - $90.86 $2.07 Million - $2.93 Million
32,243 New
32,243 $2.88 Million

Others Institutions Holding XBI

# of Institutions
893
Shares Held
94.6M
Call Options Held
18.4M
Put Options Held
31.6M
View Full List

About SPDR SER TR SPDR S&P BIOTECH E

XBI Quotes by TradingView
  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Cramer Rosenthal Mcglynn LLC Portfolio

Follow Cramer Rosenthal Mcglynn LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cramer Rosenthal Mcglynn LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cramer Rosenthal Mcglynn LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email